Aurobindo Pharma Limited Buyback
Aurobindo Pharma Buyback 2026
Tender Offer
₹1,475.00
Buyback price per share16 Apr, 2026
Last Date to buy shares17 Apr, 2026
Record DateAbout Aurobindo Pharma Limited Buyback Company
Aurobindo Pharma is an Indian multinational pharmaceutical firm, established in 1986, and is known for its generic medicines, APIs, and speciality formulations. It is one of the top 10 generic firms in the world and operates in more than 150 nations.
Read MoreAurobindo Pharma Limited Buyback Details
- Security Name Aurobindo Pharma Limited
- Buyback Price ₹1,475.00
- Face Valuet ₹1.00
- Listing at Group BSE, NSE
- Lead Manager Axis Capital Limited
- Issue Size 54,23,728 (0.93 % of Total number of equity Shares)
- Buyback Docs Letter Of Offer
Aurobindo Pharma Limited Buyback Ratio
| Categoryy | Entitlement Ratio of Buyback | Shares Offered |
|---|---|---|
| Reserved Category for Small Shareholders | / | |
| General Category for all other Eligible Shareholders | / |
Aurobindo Pharma Limited Buyback Company Financials
| 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|
| Net Worth | 32,647.00 | 29,851.00 | -- |
| Profit After Tax | 1,582.72 | 1,211.02 | 684.85 |
| Total Assets | 49,784.97 | 45,071.51 | 39,889.99 |
| Reserves And Surplus | 20,476.03 | 19,664.23 | 17,975.44 |
| Total Revenue | 32,345.58 | 29,559.25 | 25,145.97 |
| Total Borrowing | -- | -- | -- |
How to Participate in Aurobindo Pharma Limited Buyback?
Calculation of Investment in Aurobindo Pharma Limited Buyback Buyback 2026
* No. of shares stands to change according to the closing price on the record date
* For simplicity, we have considered the price on date Apr 2, 2026
Expected Profit from the Aurobindo Pharma Limited Buyback on the bases of acceptance Ratio:
| Acceptance Ratio | Amount Invested in Buyback | No. of Shares Buyback | Buyback Profit | Profit% |
|---|---|---|---|---|
| 33% | ₹180,840.68 | 44 | 6217 | 3.44% |
| 50% | ₹180,840.68 | 67 | 9467 | 5.23% |
| 75% | ₹180,840.68 | 101 | 14271 | 7.89% |
| 100% | ₹180,840.68 | 135 | 19075 | 10.55% |
Amount Invested in Buyback: ₹180,840.68
Aurobindo Pharma Limited Buyback - Necessity of the Objective
Return surplus funds to shareholders and enhance overall shareholder returns
Optimise the Company’s capital structure.
Improve financial ratios such as earnings per share and return on equity.
Enhance long-term shareholder value.
Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.
Contact Details
Aurobindo Pharma Limited Buyback
Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032
+91 40 6672 5000
info@aurobindo.com
Registrar Contact Details
Kfin Technologies Ltd.
aurobindo.buyback2026@kfintech.com
04067162222, 04079611000